cascade

Diclofenac (Diclofenacum) is a nonsteroidal benzeneacetic acid derivative with anti-inflammatory activity. Diclofenac binds and chelates both isoforms of cyclooxygenase (COX-1 and-2), thereby blocking the conversion of arachidonic acid to pro-inflammatory-proprostaglandins.

Diclofenac Diethylamine, a non-selective COX inhibitor, is utilized as a nonsteroidal anti-inflammatory drug (NSAID).

Diclofenac sodium (GP 45840) is a non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Diclofenac Potassium (CGP-45840B) is a nonsteroidal anti-inflammatory drug taken to reduce inflammation and as an analgesic reducing pain in certain conditions.

Flufenoxuron（Cascade）is a benzoylurea pesticide that inhibits chitin synthesis in insects. Flufenoxuron is toxic and suppresses the proliferation of testicular cells by targeting mitochondria in mice.

3,6-Dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.

RSK2-IN-3 (Compound 26) is a covalent, reversible inhibitor of the RPS6KA3 (RSK2) kinase.

Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.

Milvexian (BMS-986177/JNJ-70033093) is an orally bioavailable, small-molecule, reversible, and direct antagonist of Factor XIa (FXIa). It exhibits potent inhibitory activity across species, with Ki values of 0.11 nM for human, 0.38 nM for rabbit, and 0.64 nM for dog. By targeting FXIa, Milvexian selectively inhibits the intrinsic pathway of the coagulation cascade. It demonstrates robust antithrombotic efficacy in various in vitro and in vivo models while maintaining a favorable safety profile regarding bleeding risk. It is a critical tool for investigating novel anticoagulant strategies in thrombosis and cardiovascular research.

PLX7683 is a RAF inhibitor and a ‘paradox breaker’ of the MAPK pathway. PLX7683 overcomes several known mechanisms of resistance to first-generation RAF inhibitors by dissociating MAPK pathway inhibition from paradoxical activation. PLX7683 is used in kinase signaling research systems to investigate RAF pathway regulation, resistance mutation mechanisms, and MAPK cascade modulation in cancer cell models.

SF5 is an inhibitor of the apoptosis pathway. Which is through the JNK-p53-caspase apoptotic cascade.

Phospholipase A2 (PLA2) catalyzes the hydrolysis of phospholipids at the sn-2 position leading to the production of lysophospholipids and free fatty acids. Calcium-dependent cytosolic PLA2 (cPLA2α) is a 85 kDa enzyme that plays a key role in the arachidonic cascade and the inflammatory response associated with this metabolic pathway. CAY10502 is a potent inhibitor of calcium-dependent cytosolic PLA2α (cPLA2α) with an IC₅₀ value of 4.3 nM for the purified enzyme from human platelets. It inhibits arachidonic acid mobilization from A23187-stimulated or TPA-stimulated human platelets with IC₅₀ values of 570 and 0.9 nM, respectively.

Ecleralimab is a potent inhaled antibody fragment (scFv) targeting TSLP, acting by blocking the binding of TSLP to its receptor complex. The compound is an essential tool for investigating the role of airway epithelial-derived cytokines in asthma pathogenesis, aiming to alleviate Type 2 inflammatory responses by inhibiting the upstream immune cascade.

Monensin is an orally active natural antibiotic that also functions as an ion carrier mediating Na+/H+ exchange and a Wnt inhibitor, effective against Gram-positive bacteria, Plasmodium falciparum, and certain viruses.

Jasmonic acid (JA) is a phytohormone and plant growth regulator involved in plant defense and growth and development.Jasmonic acid plays an important role in signaling, inducing the MAP kinase cascade pathway and calcium channels.

TAC (TERT activator compound) is a TERT (telomerase reverse transcriptase) activator that enhances TERT transcriptional activity through the MEK/ERK/AP-1 cascade pathway, promotes telomere synthesis in primary human cells and naturally aged mice, reduces cellular senescence and inflammatory cytokines, and alleviates neuroinflammation, among other effects.

Microtubule destabilizing agent-2 (Compound 21) is an orally active and selective anticancer compound targeting microtubule proteins. It disrupts microtubule stability, inhibiting microtubule polymerization. This agent causes human tumor cells to arrest in the G0/G1 phase and induces apoptosis (Apoptosis) through activation of the Caspase cascade pathway. Additionally, it exhibits anti-inflammatory properties, inhibiting the production of TNF-α and IL-6 in vitro. Microtubule destabilizing agent-2 also suppresses tumor growth in xenograft mice.

Tubulin-IN-52 is a potent, selective tubulin polymerization inhibitor with an IC₅₀ of 2.9 μM. Tubulin-IN-52 induces apoptosis in tumor cells by triggering a caspase cascade via the mitochondrial apoptosis pathway. Tubulin-IN-52 significantly inhibits tumor growth without significant toxicity. Tubulin-IN-52 can be used in cancer-related research.

WMJ-J-09 is a novel hydroxamate-based HDAC inhibitor that induces tumor cell apoptosis by activating the LKB1-AMPK signaling cascade and downregulating Survivin.

Donidalorsen is an antisense oligonucleotide engineered to selectively reduce the production of prekallikrein (PKK), a key upstream mediator in inflammatory cascade activation, and is used in hereditary angioedema research to investigate bradykinin-driven inflammation, acute attack prevention mechanisms, and RNA-targeted therapeutic strategies.

RAS activator compound 1 is an effective small GTPase modulator and Ras-GTP signaling pathway activator. It sustainably enhances kinase cascade signaling by directly binding and stabilizing the active conformation of Ras with its effectors, commonly used to investigate Ras-driven hyperproliferation and oncogenesis.

GTPL547 is a potent quorum sensing system antagonist specifically targeting the PqsR (MvfR) transcriptional regulator in Pseudomonas aeruginosa (IC₅₀ = 12 nM). By halting the PQS-mediated gene transcription cascade, it completely suppresses the secretion of lethal virulence factors like pyocyanin and the irreversible assembly of biofilms, providing a critical lead compound for tackling multidrug-resistant infections.

3-(4-Octadecylbenzoyl)acrylic acid is an effective broad-spectrum phospholipase A2 (PLA2) inhibitor. By preventing the release of arachidonic acid from membrane phospholipids, it severs the biosynthetic cascade of prostaglandins and leukotrienes, demonstrating exceptionally potent anti-inflammatory activity in acute inflammation and tissue injury models.

ER-464195-01 is an orally active inhibitor that targets the interaction between CRT and ITGAs. By disrupting the binding of CRT and ITGAs, ER-464195-01 reduces leukocyte infiltration and subsequent inflammatory cascade reactions. It downregulates the expression of pro-inflammatory genes induced by DSS, such as [TNF-α], [IL-1β], [IL-6], [IL-17f], and inhibits the phosphorylation of STAT3 and the production of serum amyloid A (SAA). This compound is applicable for research in inflammatory bowel disease (IBD).